MihaiPuia DumitrescuMDMPH
Neonat/Perinatology • Seattle, WAHigh Risk Infant Follow-Up, Neonatal Infections, Neonatal Neurodevelopment
Assistant Professor
Dr. Puia Dumitrescu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4800 Sand Point Way NE
Seattle, WA 98105Phone+1 206-987-2000
Summary
- Dr. Mihai Puia Dumitrescu is a neonatologist at Seattle Children's Hospital. He speaks multiple languages, including Romanian. He specializes in clinical research and neonatal trials. His goal is to combine critical illness physiology, epidemiological methods, and clinical trial design to optimize drug therapy and neurodevelopmental outcomes in premature infants and critically ill neonates.
Education & Training
Duke University HospitalFellowship, Neonatal-Perinatal Medicine, 2015 - 2018
University of Miami/Jackson Health SystemResidency, Pediatrics, 2012 - 2015
University of MiamiMPH, Epidemiology, 2011 - 2012
Iuliu Hatieganu University of Medicine and PharmacyClass of 2007
Certifications & Licensure
WA State Medical License 2018 - 2025
NC State Medical License 2015 - 2023- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Neonatal-Perinatal Medicine
- American Board of Medical QualityMedical Quality
Awards, Honors, & Recognition
- Travel Award PAS, 2017
- Florida Vice President Committee of Interns and Residents, 2014-2015
- Junior Investigator Travel Awardee NIDA Women & Sex/Gender Differences Research, 2013
Publications & Presentations
PubMed
- 14 citationsDexamethasone, Prednisolone, and Methylprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants.Mihai Puia-Dumitrescu, Thomas R Wood, Bryan A Comstock, Janessa B Law, Kendell German
JAMA Network Open. 2022-03-01 - 31 citationsAssessment of 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants Receiving Opioids and Benzodiazepines.Mihai Puia-Dumitrescu, Bryan A. Comstock, Sijia Li, Patrick J. Heagerty, Krystle Perez
JAMA Network Open. 2021-07-01 - 4 citationsUse of Dexmedetomidine and Opioids in Hospitalized Preterm Infants.Samantha Curtis, Ryan Kilpatrick, Zeenia C Billimoria, Kanecia Zimmerman, Veeral Tolia
JAMA Network Open. 2023-11-01
Other Languages
- Romanian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
